6533b81ffe1ef96bd12770e3

RESEARCH PRODUCT

Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients

Filippo PelizzaroAlessandro VitaleAnna SartoriAndrea VienoBarbara PenzoFrancesco RussoAnna FrigoEdoardo GianniniManuela PiccinnuGian RapacciniMaria MarcoEugenio CaturelliMarco ZoliRodolfo SaccoCiro CelsaFabio MarraAndrea MegaMaria GuarinoAntonio GasbarriniGianluca Svegliati-baroniFrancesco FoschiAndrea OlivaniAlberto MasottoPietro CoccoliGiovanni RaimondoFrancesco AzzaroliGianpaolo VidiliMaurizia BrunettoFranco TrevisaniFabio FarinatiOn Behalf Of Ita.li.ca Study Group

subject

Cancer Researchmedicine.medical_specialtyHepatocellular carcinomaSettore MED/12 - GASTROENTEROLOGIACancer stageIndependent predictorLogistic regressionlcsh:RC254-282Article03 medical and health sciencesLong-term survival0302 clinical medicineInternal medicineLong term survivalmedicineTreatment.Surveillancebusiness.industryCancer stageSettore MED/09 - MEDICINA INTERNAConfoundingmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensTreatmentCancer stage; Hepatocellular carcinoma; Long-term survival; Surveillance; TreatmentOncology030220 oncology & carcinogenesisHepatocellular carcinomaBaseline characteristics030211 gastroenterology & hepatologybusiness

description

Purpose: We aimed at assessing the impact of surveillance on long-term survival in HCC patients. Methods: From the ITA.LI.CA database, we selected 1028 cases with long (≥5 years, LS group) and 2721 controls with short-term survival (&lt

yearjournalcountryeditionlanguage
2021-02-20
10.3390/cancers13040897http://hdl.handle.net/11585/873171